Datasea & NeuroSense regained Nasdaq compliance with minimum bid price requirements.

Datasea Inc., a digital technology corporation focused on intelligent acoustics and 5G messaging technology in China, has regained compliance with Nasdaq's minimum bid price requirement under Listing Rule 5550(a)(2). NeuroSense Therapeutics has also regained compliance with the Nasdaq minimum bid price listing requirement, maintaining a minimum closing bid price of $1.00 or more for at least 10 consecutive business days. In both cases, the regained compliance is considered an important event as companies continue to focus on their growth and developments in their respective sectors.

February 07, 2024
4 Articles

Further Reading